This page contains summaries of decisions made by the NENC Medicines Subcommittee and its subgroups. Summaries are published following each meeting of the NENC Medicines Subcommittee.

Title Documents Decision Date

New

08/12/2023
Medicines Subcommittee decision summary December 2023 Medicines Committee decision summary - December 2023 Approved 07/12/2023
Medicines Committee decision - NICE TA 929 - Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction Medicines Committee decision - NICE TA 929 - Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction Approved 20/11/2023
Medicines Committee Decision Summary - NICE TA918, TA920, TA925, TA927 - Nov 2023 Medicines Committee decision - NICE TA918, TA920, TA925, TA927 - Nov 2023 Approved 15/11/2023
Medicines Subcommittee decision summary October 2023 Medicines Committee decision summary - October 2023 v2 Approved 14/11/2023
Medicines Decision Summary - 30-day NICE TA916 - Oct 2023 Medicines Committee decision - NICE TA 916 - Bimekizumab PsA Approved 19/10/2023
Medicines Subcommittee decision summary September 2023 Medicines Committee decision summary - September 2023 - FNL Approved 02/10/2023
Medicines Subcommittee decision summary June 2023 Medicines Committee decision summary Jun 2023 - FNL Approved 20/06/2023
Medicines Subcommittee decision summary April 2023 Medicines Committee decision summary April 23 approved by ICB director 180523 Approved 18/05/2023
Medicines Decision Summary from March 2023 NENC ICB Executive Committee Medicines Decision Summary from March 2023 NENC ICB Executive Committee - final without VBC updates Approved 14/03/2023
Medicines Decision Summary - 30-day NICE TA861 - Feb 2023 Medicines Decision Summary - 30-day NICE TA861 - Feb 2023 Approved 14/03/2023
Medicines Decision Summary from January 2023 NENC ICB Executive Committee Medicines Decision Summary from January 2023 NENC ICB Executive Committee - final Approved 10/01/2023
Medicines Decision Summary from December 2022 NENC ICB Executive Committee Medicines Decision Summary from December 2022 NENC ICB Executive Committee - final Approved 13/12/2022